Atlas FDA

XPS™ with Steen Solution™ Perfusate

FDA premarket approval P180014 · decided 2019-04-26

Approval details

PMA number
P180014
Trade name
XPS™ with Steen Solution™ Perfusate
Generic name
Normothermic preservation system for transplantation of initially unacceptable donor lungs
Applicant
Xvivo Perfusion, Inc.
Date received
2018-05-10
Decision date
2019-04-26
Days to decision
351 days
Decision code
APPR
Product code
PHO
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Englewood, CO
Statement
Approval for the XPS™ with Steen Solution™ Perfusate. This device is indicated for use in flushing and temporary continuous normothermic machine perfusion of initially unacceptable excised donor lungs during which time the ex vivo function of the lungs can be reassessed for transplantation.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.